IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.

Svalina, Matthew N

IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma. [electronic resource] - Scientific reports 06 2016 - 27012 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

2045-2322

10.1038/srep27012 doi


Adolescent
Antineoplastic Agents--pharmacology
Biomarkers, Tumor--antagonists & inhibitors
Case-Control Studies
Cell Adhesion
Cell Line, Tumor
Cell Movement
Cell Proliferation
Cerebellar Neoplasms--cerebrospinal fluid
Child
Drug Screening Assays, Antitumor
Female
Gene Expression
Humans
Inhibitory Concentration 50
Insulin-Like Growth Factor Binding Protein 3--cerebrospinal fluid
Insulin-Like Growth Factor I--cerebrospinal fluid
Male
Matrix Metalloproteinase 9--cerebrospinal fluid
Medulloblastoma--cerebrospinal fluid
Meningeal Neoplasms--cerebrospinal fluid
Molecular Targeted Therapy
Plasminogen Activator Inhibitor 1--cerebrospinal fluid
Receptor, IGF Type 1
Receptors, Somatomedin--antagonists & inhibitors
Tissue Inhibitor of Metalloproteinase-1--cerebrospinal fluid